Paola Storici

Cross-border Italy-Slovenia biomedical research: Are we ready for horizon 2020? Conference proceedings with an analysis of innovation management and knowledge transfer potential for a smart specialization strategy

Sabina Passamonti, Rado Pišot, Tamara Lah Turnšek, 2014 .

A consensus protocol for the in silico optimisation of antibody fragments.

Alessandro Laio, Paola Storici, Miguel A. Soler, 2019, Chemical communications.

Crystal structure of osmoporin OmpC from E. coli at 2.0 A.

Paola Storici, Arnaud Baslé, G. Rummel, 2006, Journal of molecular biology.

1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profile.

Paola Storici, Maurizio Rocchetti, Enrico Pesenti, 2006, Journal of medicinal chemistry.

From protein structure to function via single crystal optical spectroscopy

Paola Storici, Andrea Mozzarelli, Luca Ronda, 2015, Front. Mol. Biosci..

Structures of γ-Aminobutyric Acid (GABA) Aminotransferase, a Pyridoxal 5′-Phosphate, and [2Fe-2S] Cluster-containing Enzyme, Complexed with γ-Ethynyl-GABA and with the Antiepilepsy Drug Vigabatrin*

Paola Storici, Francesco Bossa, Andrea Mozzarelli, 2003, Journal of Biological Chemistry.

PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer

Paola Storici, Cristina Alli, Maurizio Rocchetti, 2007, Molecular Cancer Therapeutics.